Based on evidence and literature tell me the dose titration of excimer laser in vitiligo and also tell maximum allowance of dose in indian population

Reading File
Reading File
Reading File
Searching the Web

vitiligo 308 nm excimer laser dosing protocol starting dose dose increment maximum dose India guidelines

Finding Sources
Searching PubMed

vitiligo AND excimer laser

Searching PubMed

vitiligo AND excimer laser

Reading Web Page

https://ijdvl.com/ultraviolet-based-therapy-for-vitiligo-wha…

Finding Sources
Reading Article

PMID: 15888156

Reading Article

PMID: 21779415

Searching the Web

IADVL vitiligo 308 nm excimer laser dose mJ cm2 maximum dose guideline Indian population

Reading Web Page

https://ijdvl.com/minimal-erythema-dose-to-targeted-photothe…

Reading Article

PMID: 12890118

Finding Sources

308-nm excimer laser dose titration for vitiligo

Excimer laser is mainly used for localized vitiligo. It is usually administered 2-3 times weekly, with at least 24 hours between sessions. Fitzpatrick’s notes that response depends more on the total number of treatments than frequency, although 3 weekly sessions may produce earlier repigmentation. Face, neck, and trunk generally respond better than acral sites. Fitzpatrick’s summary

Practical evidence-based protocol

StepSuggested approach
Before startingDocument lesion photographs and perform a 308-nm MED test where feasible, especially in darker phototypes and on site-specific lesions.
Starting dose, MED-basedStart at approximately 70% of the 308-nm MED, or 50 mJ/cm² below the lesional MED.
Starting dose, fixed-dose alternative100-150 mJ/cm² is a conservative and commonly reported start. A fixed 150 mJ/cm² is used in an Indian review protocol. Some studies begin at 200 mJ/cm², but this is less conservative, particularly on the face.
Increment if no erythema at 24 hIncrease 10-15% each session. Published excimer protocols range from 10-25%, occasionally up to 30%, but 10-15% is a sensible routine increment.
Faint, asymptomatic erythema lasting <24 hContinue the same dose, or use a smaller increment of about 5-10%.
Symptomatic erythema, erythema lasting >24-48 h, edema, tenderness, or blisterWithhold treatment until resolved. Resume at the last well-tolerated dose or reduce by about 10-25%, depending on severity. Do not escalate through phototoxicity.
Course assessmentTreat 2-3 times weekly and reassess after about 24-36 sessions. Many protocols allow up to 48-60 sessions before considering a lesion nonresponsive.
A clinical trial of localized vitiligo used 100 mJ/cm² initially, with 10-25% increments, twice weekly for up to 60 treatments. Taneja et al., 2003, PMID: 12890118 A randomized frequency study used an initial exposure 50 mJ/cm² below the 308-nm MED in vitiligo skin, then adjusted each treatment based on erythema. Hofer et al., 2005, PMID: 15888156

Maximum dose: what to use in Indian patients?

Practical ceiling

For routine 308-nm excimer laser treatment in Indian patients, a reasonable working ceiling is:
  • Face, neck, and other sensitive sites: 1,000 mJ/cm² (1 J/cm²)
  • Trunk and limbs: 3,000 mJ/cm² (3 J/cm²)
This 150 mJ/cm² start, 15% escalation, and upper limit of 1 J/cm² on the face and 3 J/cm² on the body is stated in an Indian dermatology review of UV therapy for vitiligo. IJDVL dosing review

Important qualification

There is no validated, India-specific universal maximum dose for 308-nm excimer laser based solely on Fitzpatrick skin type or ethnicity. Dose tolerance varies by:
  • anatomic site, especially low facial and high acral tolerance variability
  • prior UV exposure and tanning
  • active inflammation or friction
  • concurrent topical agents
  • individual MED and prior phototoxic reactions
  • device calibration and spot geometry
An Indian study of targeted 305-nm UVB lamp therapy, not 308-nm excimer laser, found highly variable MEDs among phototypes IV-VI: 200-1500 mJ/cm², median 600 mJ/cm². This supports individual MED-based dosing but should not be treated as a direct excimer-laser maximum-dose table because the wavelength and device differ. Indian MED study

What not to interpret as a routine limit

Older excimer series have reported doses reaching 6,000 mJ/cm², especially in resistant sites. That is a reported study exposure, not a recommended maximum allowance for routine practice. Escalating to high doses, particularly on the face, solely because the patient has darker skin is not evidence-based.

A simple clinic-ready regimen

For a patient with localized non-acral vitiligo:
  1. MED test preferred, especially in Indian phototypes IV-VI.
  2. If MED unavailable, start:
    • Face: 100-150 mJ/cm²
    • Trunk/limbs: 150-200 mJ/cm², cautiously
  3. Increase by 10-15% per session if there is no clinically relevant erythema at the next visit.
  4. Maintain the previous dose if mild transient erythema occurs.
  5. Stop temporarily for painful erythema or blistering; restart at the prior tolerated dose or 10-25% lower.
  6. Avoid routinely exceeding:
    • 1,000 mJ/cm² face
    • 3,000 mJ/cm² trunk/limbs
  7. For hands, feet, elbows, knees, and other acral/bony sites, use an MED-guided rather than an automatic high-dose strategy. These sites often respond poorly despite higher tolerable doses.
Recent systematic reviews support excimer light as an effective treatment, particularly in combination regimens, but do not establish a superior universal titration schedule or a higher dose ceiling for Indian skin: Liu et al., 2026, systematic review and network meta-analysis, PMID: 41564112; Li et al., 2024, systematic review, PMID: 38230424.
This should be used as a dermatologist-supervised phototherapy protocol, with eye protection and strict avoidance of treating photosensitive, infected, or blistered skin.
This is a shared conversation. Sign in to Orris to start your own chat.